Skip to content
Clinical Trials – home
Astellas Gene Therapies Inc.
Sponsor

Astellas Gene Therapies Inc.

United States 480 Forbes Boulevard, 94080-2015, United States

About the sponsor

Astellas Gene Therapies Inc. focuses on gene therapy approaches for X-linked Myotubular Myopathy (XLMTM), a severe neuromuscular disorder that affects muscle strength and respiratory function.

  • XLMTM
  • AT132
  • Muscle weakness
  • Neuromuscular disease

The research activity is centered on therapies intended to address the underlying genetic basis of the condition.

About Specializations

Astellas Gene Therapies Inc. runs clinical trials in conditions such as Congenital myopathy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:FranceFrance
  • Participants:0–17 years
  • Substances:ASP2957
  • Sponsor:Astellas Gene Therapies Inc.
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Resamirigene Bilparvovec
  • Sponsor:Astellas Gene Therapies Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.